The Journal of the Korean Rheumatism Association 2007; 14(3): 227-234
Published online September 30, 2007
© Korean College of Rheumatology
박성훈ㆍ김지영ㆍ김성규ㆍ최정윤ㆍ김상경*ㆍ신임희**
대구가톨릭대학교 의과대학 내과학교실, 진단검사의학교실*, 의학통계학교실**
Correspondence to : Jung-Yoon Choe
Objective:To identify the sensitivity and specificity of the anti-cyclic citrullinated peptide antibody (anti-CCP) and rheumatoid factor (RF) in a diagnosis of Korean early rheumatoid arthritis (RA). Methods:Two hundred and sixty two patients diagnosed with RA were examined retrospectively and classified by three groups. A group 1 had a disease duration<24 months, and group 2 had a duration>24 months, and the third was a group of total patients. The sensitivity and specificity of the RF and anti-CCP in each group of RA were identified. Patients of the connective tissue disease other than rheumatoid arthritis were tested with RF and anti-CCP. Results: The sensitivity/specificity of RF and the anti-CCP in early RA were 90.4%/68.0% and 87.5%/89.3%, 91.3%/68.0%, 81.7%/89.3% in each, and 90.4%/68.0% and 84.7%/89.3% in the total RA patients. The accurate diagnosis rate, which is defined as (number of true positives plus true negatives)/ the total number of patients), of the RF and anti-CCP was 79.2%/88.4% in the early RA group, and 79.4% and 89.0% in the total patients group. Conclusion: Anti-CCP is more specific than RF in diagnosing RA. Although it is not statistically significant, diagnositc sensitivity of anti-CCP in early RA group is higher than that of established RA group.
Keywords Rheumatoid arthritis, Rheumatoid factor, Anti-cyclic citrullinated peptide
The Journal of the Korean Rheumatism Association 2007; 14(3): 227-234
Published online September 30, 2007
Copyright © Korean College of Rheumatology.
박성훈ㆍ김지영ㆍ김성규ㆍ최정윤ㆍ김상경*ㆍ신임희**
대구가톨릭대학교 의과대학 내과학교실, 진단검사의학교실*, 의학통계학교실**
Sung-Hoon Park, Ji-Young Kim, Seong-Kyu Kim, Jung-Yoon Choe, Sang Kyung Kim*, Im-Hee Shin**
Departments of Internal Medicine, Laboratory Diagnostics*, and Medical Statistics**, School of Medicine, The Catholic University of Daegu, Daegu, Korea
Correspondence to:Jung-Yoon Choe
Objective:To identify the sensitivity and specificity of the anti-cyclic citrullinated peptide antibody (anti-CCP) and rheumatoid factor (RF) in a diagnosis of Korean early rheumatoid arthritis (RA). Methods:Two hundred and sixty two patients diagnosed with RA were examined retrospectively and classified by three groups. A group 1 had a disease duration<24 months, and group 2 had a duration>24 months, and the third was a group of total patients. The sensitivity and specificity of the RF and anti-CCP in each group of RA were identified. Patients of the connective tissue disease other than rheumatoid arthritis were tested with RF and anti-CCP. Results: The sensitivity/specificity of RF and the anti-CCP in early RA were 90.4%/68.0% and 87.5%/89.3%, 91.3%/68.0%, 81.7%/89.3% in each, and 90.4%/68.0% and 84.7%/89.3% in the total RA patients. The accurate diagnosis rate, which is defined as (number of true positives plus true negatives)/ the total number of patients), of the RF and anti-CCP was 79.2%/88.4% in the early RA group, and 79.4% and 89.0% in the total patients group. Conclusion: Anti-CCP is more specific than RF in diagnosing RA. Although it is not statistically significant, diagnositc sensitivity of anti-CCP in early RA group is higher than that of established RA group.
Keywords: Rheumatoid arthritis, Rheumatoid factor, Anti-cyclic citrullinated peptide
Kyeong Hee Kim, M.D., Sung Won Lee, M.D.*, Won Tae Chung, M.D.*
The Journal of the Korean Rheumatism Association 2006; 13(1): 46-51Roshan Subedi, M.D., Afrah Misbah, M.D., Adnan Al Najada, M.D., Anthony James Ocon, M.D., Ph.D.
J Rheum Dis -0001; ():Hee Jun Kim, R.N., Ph.D., Ju-Yang Jung, M.D., Ph.D., Ji-Won Kim, M.D., Chang-Hee Suh, M.D., Ph.D., Hyoun-Ah Kim, M.D., Ph.D.
J Rheum Dis -0001; ():